HIBICLENS Drug Patent Profile
✉ Email this page to a colleague
When do Hibiclens patents expire, and when can generic versions of Hibiclens launch?
Hibiclens is a drug marketed by Molnlycke Hlth and is included in two NDAs.
The generic ingredient in HIBICLENS is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hibiclens
A generic version of HIBICLENS was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.
Summary for HIBICLENS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Clinical Trials: | 14 |
Patent Applications: | 6,899 |
Formulation / Manufacturing: | see details |
Drug Sales Revenues: | Drug sales revenues for HIBICLENS |
What excipients (inactive ingredients) are in HIBICLENS? | HIBICLENS excipients list |
DailyMed Link: | HIBICLENS at DailyMed |
Recent Clinical Trials for HIBICLENS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Missouri-Columbia | Phase 4 |
Carilion Clinic | Phase 4 |
University of Washington | Phase 4 |
Pharmacology for HIBICLENS
Physiological Effect | Decreased Cell Wall Integrity |
Anatomical Therapeutic Chemical (ATC) Classes for HIBICLENS
US Patents and Regulatory Information for HIBICLENS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SOLUTION;TOPICAL | 017768-001 | Approved Prior to Jan 1, 1982 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SPONGE;TOPICAL | 018423-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HIBICLENS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SPONGE;TOPICAL | 018423-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SPONGE;TOPICAL | 018423-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SOLUTION;TOPICAL | 017768-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SPONGE;TOPICAL | 018423-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for HIBICLENS
See the table below for patents covering HIBICLENS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 459343 | ⤷ Try a Trial | |
Canada | 969442 | CLEANSING COMPOSITIONS | ⤷ Try a Trial |
Denmark | 124586 | ⤷ Try a Trial | |
Germany | 1617836 | HAARBEHANDLUNGSMITTEL ZUR BESEITIGUNG VON SCHUPPEN AUF DER KOPFHAUT | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |